HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kate Newberry Selected Research

ibrutinib

8/2013Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kate Newberry Research Topics

Disease

4Primary Myelofibrosis (Myelosclerosis)
01/2017 - 09/2014
3Neoplasms (Cancer)
10/2021 - 08/2013
2Leukemia
01/2017 - 03/2015
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2014 - 08/2013
1Disease Progression
10/2021
1Thrombocytosis (Thrombocythemia)
01/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2015
1Anemia
09/2014
1Multiple Myeloma
06/2014
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2014
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2013

Drug/Important Bio-Agent (IBA)

2Janus KinasesIBA
01/2017 - 03/2015
2Lenalidomide (CC 5013)FDA Link
08/2015 - 06/2014
2ruxolitinibIBA
08/2015 - 03/2015
1avapritinibIBA
10/2021
1regorafenibIBA
10/2021
1Tyrosine Kinase InhibitorsIBA
10/2021
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2021
1Janus Kinase 2IBA
01/2017
1CalreticulinIBA
01/2017
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2015
1pomalidomideIBA
09/2014
1Hemoglobins (Hemoglobin)IBA
09/2014
1Prednisone (Sone)FDA LinkGeneric
09/2014
1ibrutinibIBA
08/2013
1Agammaglobulinaemia Tyrosine KinaseIBA
08/2013

Therapy/Procedure

3Therapeutics
01/2017 - 09/2014